April 15, 2024 – LICORbio LAUNCHES TWO NEW IMAGING SYSTEMS
April 8, 2024 – LI-COR Biotechnology Unveils New Brand
December 1, 2023 – LI-COR Announces New Biotech Distributor in Taiwan
December 8, 2021 – Battery Ventures Acquires Analytical-Instrumentation Pioneer LI-COR Biosciences
January 11, 2021 – LI-COR Biosciences Providing Direct Support to Customers in Italy
January 11, 2021 – Rakuten Medical, Inc. Acquires Key Assets and Manufacturing Technology from LI-COR Biosciences
July 7, 2020 – LI-COR Near-Infrared Assays and Technology Offer Insight to Coronavirus Researchers
January 27, 2020 – New JBC Manuscript Promotes Industry-Leading Best Practice Guidance on Antibody Validation via Western Blotting
December 10, 2019 – LI-COR Announces Partnership with The Antibody Registry
August 6, 2019 – LI-COR Biosciences Introduces DigiWest® to Accelerate Targeted Therapeutics Development
May 15, 2018 – LI-COR Announces New Biotech Distributor for Singapore, Malaysia, Thailand, and Vietnam
April 30, 2018 – LI-COR Announces New Biotech Distributor in Israel
April 13, 2018 – LI-COR Announces New Biotech Distributor in Korea
April 10, 2018 – LI-COR Announces New Biotech Distributor in Japan
July 6, 2017 – LI-COR Introduces Nucleic Acid Gel Analysis With A Safe, Consistent, Single-System Workflow
March 29, 2017 – LI-COR Sponsors Clinical Trial For Near Infrared Surgical Imaging
March 9, 2017 - Growing Concern Over Reliability of Experiments Adds Pressure for Researchers
June 20, 2016 – LI-COR Licenses IRDye technology to QVQ for Pre-Clinical Cancer Research
Mar 5, 2015 - Aura Biosciences Closes $21M Series B Financing - Prepares to enter clinical trials for the treatment of rare ocular cancers
Apr 21, 2010 - Study Published on Toxicity of IRDye®® 800CW Carboxylate in Sprague Dawley Rats
Oct 21, 2009 - LI-COR Reports on Toxicity Study of its IRDye® 800CW Carboxylate at Global Imaging Summit in Berlin
Sep 10, 2007 - LI-COR Infrared Dye Successfully Completes Toxicity Studies